
Chemical and Pharmaceutical Bulletin p. 1889 - 1898 (1985)
Update date:2022-08-02
Topics:
Sugai
Okazaki
Kajiwara
Kanbara
Naito
Yoshida
Akaboshi
Ikegami
Kamano
Seven 17-ester and thirty-eight 17,21-diester compounds (3 and 4) of 11β,17α,21-trihydroxy-6α-methyl-1,4-pregnadiene-3,20-dione (6α-methylprednisolone, 1) were synthesized and thirty-eight selected compounds were tested for vasoconstrictive activity in humans. Except for 4g1 and 4g2, they were more active than the mother compound (1). In particular, the activities of ten compounds (3b-g, 4b9,10, 4c2,3, and 4c6) were equal to or greater than that of 9α-fluoro-11β,21-dihydroxy-16β-methyl-17α-valeryloxy-1,4-pregnadiene-3 ,20-dione (betamethasone 17-valerate, BV). The activities of 21-methoxyacetate compounds (4b9, 4c6 and 4d5) were potent. The structure-activity relationship is discussed.
View MoreHangzhou GreenCo Science & Technology Co., Ltd.
Contact:86-571-88257303
Address:1713 Room,Jingui Building,Gudun Road,Xihu District,Hangzhou,China
Shanghai Gsyn Chemical Co.,Ltd.
Contact:86-021-67158290
Address:86-021-67158291
Taizhou YOJOY Chemical Co., Ltd.
Contact:13857143241
Address:Yangfu Industrial Park, Xianju, Zhejiang, P. R. China
Quzhou Aokai Chemical Co., Ltd.
Contact:86-570-3032832
Address:NO.16 , Laodong Road,Quzhou City, Zhejiang Province,China
Contact:0086-27-83607103/83642615
Address:No.498, Jianshe Ave, Wuhan, China
Doi:10.1002/chem.201805490
(2019)Doi:10.1021/jo202054g
(2012)Doi:10.1246/bcsj.58.1421
(1985)Doi:10.1246/bcsj.57.3476
(1984)Doi:10.1021/ja01490a028
(1960)Doi:10.1002/hlca.19730560739
(1973)